Liver Cirrhosis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

6 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liver Cirrhosis
NCT02011932: Prospective Observational Study of Disease Progression in Chronic Hepatitis C

Active, not recruiting
N/A
133
RoW
Beijing YouAn Hospital
Hepatitis C, Chronic, Disease Progression, Liver Cirrhosis
06/11
07/30
NCT01508286 / 2010-023669-23: Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Checkmark BWG 2014: HEP3002
Aug 2014 - Aug 2014: BWG 2014: HEP3002
Checkmark BWG 2014: HEP3002
Aug 2014 - Aug 2014: BWG 2014: HEP3002
Checkmark HEP3002
More
No Longer Available
N/A
Europe, RoW
Telaprevir + peginterferon alfa + ribavirin, experimental, peginterferon alfa + ribavirin
Janssen-Cilag International NV
Hepatitis C
 
 
NCT02161939: A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

Checkmark
Jul 2014 - Jul 2014: 
No Longer Available
N/A
US
Daclatasvir (BMS-790052), Sofosbuvir
Bristol-Myers Squibb
Chronic Hepatitis C
 
 
CETRA, NCT02038517: Cirrhosis, Effects of TRAnsplantation and Diabetes

Recruiting
N/A
200
Europe
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Liver Cirrhosis
12/16
12/26
NCT01306071: Observational Study of Persons With Hepatitis B Virus Infection in North America

Recruiting
N/A
200
US
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative
 
 
NCT02037867: Nottingham Community Liver Biomarkers Cohort

Recruiting
N/A
2000
Europe
Fibrosis Biomarkers, AST:ALT ratio, APRI, BARD score, ELF Score, FIB4, NAFLD Fibrosis Score,Transient Elastography
University of Nottingham
Chronic Liver Disease, Alcohol Use Disorder, Type 2 Diabetes, Persistently Elevated ALT, Obesity
05/33
05/33

Download Options